KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Net Income (2017 - 2025)

Guardant Health (GH) has disclosed Net Income for 9 consecutive years, with -$128.5 million as the latest value for Q4 2025.

  • Quarterly Net Income fell 15.75% to -$128.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$416.3 million through Dec 2025, up 4.61% year-over-year, with the annual reading at -$416.3 million for FY2025, 4.61% up from the prior year.
  • Net Income hit -$128.5 million in Q4 2025 for Guardant Health, down from -$92.7 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$72.3 million in Q4 2021 to a low of -$229.4 million in Q2 2022.
  • Historically, Net Income has averaged -$118.6 million across 5 years, with a median of -$107.6 million in 2021.
  • Biggest five-year swings in Net Income: crashed 237.3% in 2021 and later skyrocketed 68.28% in 2023.
  • Year by year, Net Income stood at -$72.3 million in 2021, then crashed by 93.52% to -$139.9 million in 2022, then tumbled by 33.67% to -$187.0 million in 2023, then skyrocketed by 40.65% to -$111.0 million in 2024, then fell by 15.75% to -$128.5 million in 2025.
  • Business Quant data shows Net Income for GH at -$128.5 million in Q4 2025, -$92.7 million in Q3 2025, and -$99.9 million in Q2 2025.